Publication:
Uveitis in Patients with Autoimmune Hepatitis

dc.contributor.authorLyndell L. Limen_US
dc.contributor.authorJohn D. Scarboroughen_US
dc.contributor.authorJennifer E. Thorneen_US
dc.contributor.authorElizabeth Grahamen_US
dc.contributor.authorJohn H. Kempenen_US
dc.contributor.authorFriederike Mackensenen_US
dc.contributor.authorQuan Dong Nguyenen_US
dc.contributor.authorTisha Prabriputaloongen_US
dc.contributor.authorRussell W. Readen_US
dc.contributor.authorEric B. Suhleren_US
dc.contributor.authorJonathan M. Schwartzen_US
dc.contributor.authorJustine R. Smithen_US
dc.contributor.otherOHSU School of Medicineen_US
dc.contributor.otherOregon Health and Science Universityen_US
dc.contributor.otherUniversity of Melbourneen_US
dc.contributor.otherThe Wilmer Eye Institute at Johns Hopkinsen_US
dc.contributor.otherGuy's and St Thomas' NHS Foundation Trusten_US
dc.contributor.otherUniversity of Pennsylvania, Health Systemen_US
dc.contributor.otherUniversitat Heidelbergen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Alabama at Birminghamen_US
dc.date.accessioned2018-09-13T07:06:11Z
dc.date.available2018-09-13T07:06:11Z
dc.date.issued2009-02-01en_US
dc.description.abstractPurpose: To report seven cases of uveitis occurring in patients with autoimmune hepatitis (AIH), raising the possibility that uveitis may be an extrahepatic feature of AIH. Design: Multicenter, retrospective, observational case series of patients with AIH and uveitis. Methods: One index case was identified at Oregon Health & Science University. Further cases were identified by a web-based survey of members of the American Uveitis Society, the International Uveitis Study Group, the Proctor Foundation mailing list server, and the First SUN International Workshop. Respondents were asked to provide clinical information about uveitis phenotype, AIH features, and treatment. Results: Clinical information was obtained for seven individuals (four females and three males; age range, seven to 67 years) who suffered from AIH and uveitis. Average duration of follow-up was 5.5 years. All patients had chronic, persistent bilateral uveitis that was anterior (n = 3), intermediate (n = 1), or pan (n = 3) in location. Every patient had complications arising from his or her uveitis, including cataract (n = 5), glaucoma (n = 3), cystoid macular edema (n = 3), and posterior synechiae (n = 3). Final visual acuities ranged from 20/16 to hand movements. To treat the uveitis and/or AIH, the majority of patients required oral prednisone and all seven patients were treated with systemic immunosuppression. Conclusion: Despite the small size of this study, our findings suggest an association between AIH and uveitis. The uveitis is chronic, bilateral, and associated with sight-threatening complications, necessitating systemic immunosuppression in some individuals. © 2009 Elsevier Inc. All rights reserved.en_US
dc.identifier.citationAmerican Journal of Ophthalmology. Vol.147, No.2 (2009)en_US
dc.identifier.doi10.1016/j.ajo.2008.08.019en_US
dc.identifier.issn00029394en_US
dc.identifier.other2-s2.0-58249098858en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/28211
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=58249098858&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleUveitis in Patients with Autoimmune Hepatitisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=58249098858&origin=inwarden_US

Files

Collections